The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
INTRAROSA (Theramex Australia Pty Ltd)
Product name
INTRAROSA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
150 (175 working days)
Registration type
NCE/NBE
Indication
INTRAROSA is indicated for the treatment of vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms.